| Fresenius Kabi (Schweiz) AG - Idacio 40 mg/ 0.8 ml, Injektionslösung in Durchstechflasche | | 67311 | | 01 | | Idacio 40 mg/ 0.8 ml | | Injektionslösung in Durchstechflasche | | L04AB04 | | Adalimumab | | 17.03.2020 | | |
| | Composition | | Lösung: adalimumabum 40 mg, acidum citricum monohydricum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, mannitolum, polysorbatum 80, natrii chloridum, trinatrii citras dihydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose | additional_information |
|---|
| Adalimumab | 40mg / 0.8ml | Lösung |
| | BAG: Active Agent | Dose |
|---|
| Adalimumab | 40 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate Dihydrate | | Mannitol | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Sodium Hydroxide | | Polysorbatum 80 | | Trinatrii Citras Dihydricus |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
